Teladoc Health, Inc. $TDOC Shares Acquired by Allianz Asset Management GmbH

Allianz Asset Management GmbH lifted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 2,605.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 559,933 shares of the health services provider’s stock after acquiring an additional 539,233 shares during the period. Allianz Asset Management GmbH’s holdings in Teladoc Health were worth $4,877,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Capital Advisors Inc. OK purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at about $174,000. Bank Hapoalim BM purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at about $777,000. Impact Investors Inc raised its holdings in shares of Teladoc Health by 17.6% during the 2nd quarter. Impact Investors Inc now owns 21,620 shares of the health services provider’s stock valued at $188,000 after buying an additional 3,232 shares during the period. Ameritas Advisory Services LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at about $78,000. Finally, Brave Asset Management Inc. purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at about $131,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several analyst reports. Zacks Research upgraded Teladoc Health from a “hold” rating to a “strong-buy” rating in a report on Friday, October 10th. Mizuho initiated coverage on Teladoc Health in a report on Friday, July 25th. They set a “neutral” rating and a $10.00 price objective on the stock. Citigroup lifted their price objective on Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a report on Tuesday. Evercore ISI lifted their price objective on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Wednesday, October 8th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Teladoc Health has an average rating of “Hold” and an average target price of $9.97.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $8.60 on Friday. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of -7.22 and a beta of 1.90. The business has a 50 day simple moving average of $8.07 and a 200-day simple moving average of $7.65.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the business earned ($0.38) EPS. The business’s quarterly revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.